Transepidermal treatment to improve scars.
Legato II is a clinically proven ablative fractional radiofrequency skin rejuvenation treatment to treat scars and other skin imperfections such as lines, superficial pigmentation, pores and stretch marks.
This second generation of Legato II uses ultrasound technology: MICROPLASMA™, MICROPEEL™ and IMPACT™.
The MICROPLASMA ™ module has a series of interchangeable heads that allow the precise level of ablation and control of thermal resistance, making it a much more comfortable treatment.
The MICROPEEL module is a fractional ablative skin rejuvenation treatment that improves the overall texture, tone and luminosity of the skin, restoring its elasticity, stimulating cell renewal and the formation of new collagen.
The IMPACT module uses ultrasound technology to deeply drive the active ingredients until they reach the desired tissue layer.
Legato II is suitable for all skin types and involves minimal recovery time and minimal side effects.
